BALLOON (Corticosteroid/laBA inhaLers in adoLescents' Asthma: Assessment Of Patients satisfactiON) Study
NCT01708486 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2014-08-19
Summary
Patients' satisfaction with their asthma medication devices is usually decided by using properly designed questionnaires. These questionnaires are to be used to evaluate patients' opinion, which is considered very important for the selection of a device.
The Feeling of Satisfaction with Inhaler (FSI-10) is a self-completed questionnaire designed to assess the patient opinion regarding the satisfaction and usability of the inhalers irrespectively of the drug used. It consists of 10 question each with 5 possible responses on a 5-point Likert scale scored from 5 to 1, respectively. The total score can range between 10 and 50. The higher the score, the higher the feeling of patient satisfaction from the inhaler.
Conditions
Sponsors & Collaborators
-
Elpen Pharmaceutical Co. Inc.
lead INDUSTRY
Principal Investigators
-
Ch Hatzimihael, MD Professor · Democretion University of Alexandroupolis, Pediatric Department, Thrace, Greece
-
Emm Paraskakis, MD, Ass Professor · Demokretion University of Alexandroupolis, Pediatric Department, Thrace, Greece
-
Ath Kaditis, MD · Agia Sofia Childrens Hospital of Athens, University Pediatric Clinic, Pulmonology Department
-
Poly Panayotopoulou, MD · Agia Sofia Childrens Hospital of Athens, University Pediatric Clinic, Pulmonology Department
-
Dimos Gidaris, MD Pulmonologist · Hippokration Hospital of Thessaloniki, Scientific collaborator
-
Michael Anthrakopoulos, MD, Associate Professor · University Hospital of Rio, Patras, Greece
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- Greece
Study Locations
More Related Trials
-
Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
NCT00497237 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Children
NCT00515775 ·Status: COMPLETED
-
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma
NCT02040766 ·Status: COMPLETED ·Phase: PHASE3
-
Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers
NCT05111262 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Real-world Effectiveness of Combination Therapy in Asthma
NCT01141465 ·Status: COMPLETED
-
Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children
NCT01584492 ·Status: COMPLETED ·Phase: PHASE2
-
STudy of Asthma Adherence Reminders
NCT02451709 ·Status: COMPLETED ·Phase: NA
-
Treatment Of Symptomatic Asthma In Children
NCT00197106 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils
NCT02693769 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis
NCT02345993 ·Status: UNKNOWN ·Phase: PHASE4
-
FACTO Study (Foster® As Complete Treatment Option)
NCT00901368 ·Status: COMPLETED ·Phase: PHASE4
-
Sphingosine-1-phosphate in Asthma
NCT04134351 ·Status: UNKNOWN ·Phase: NA
-
Ex Vivo Pilot Study of the Impact of Nasal Breathing During the Administration of Inhaled Corticosteroids by Inhalation Chamber in Asthmatic Children Ages Between 1 and 4-year-old
NCT03364959 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma
NCT00528723 ·Status: COMPLETED ·Phase: PHASE3
-
A Pragmatic Trial of Corticosteroid Optimisation in Severe Asthma
NCT02717689 ·Status: COMPLETED ·Phase: NA
-
Childhood Asthma Perception Study
NCT02702687 ·Status: COMPLETED ·Phase: NA
-
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
NCT01704495 ·Status: COMPLETED ·Phase: PHASE2
-
Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids
NCT01449162 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists
NCT05110976 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma
NCT02446418 ·Status: COMPLETED ·Phase: PHASE3
-
Determinants Of Oral Corticosteroid Responsiveness in Wheezing Asthmatic Youth
NCT02013076 ·Status: COMPLETED
-
A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma
NCT00384189 ·Status: COMPLETED ·Phase: PHASE3
-
As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma
NCT00382889 ·Status: COMPLETED ·Phase: PHASE3
-
Written Asthma Actions Plans Versus No Written Instructions In Specialty Care
NCT00149461 ·Status: COMPLETED ·Phase: NA
-
A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)
NCT01245426 ·Status: COMPLETED ·Phase: PHASE2